Navigating Coverage Decisions for Cell & Gene Therapies: A Payer Perspective
- Balancing clinical evidence standards, financial risk and member access
- Supporting employer evaluation of high-cost therapies, including the use of carveouts, reinsurance, and care management strategies.
- Assessing differences between large and small employer groups and their sensitivity to single high-cost claims